Cyclosporine [clinicaltrials_resource:d5ad0819e34429f7e4abc786a3f5366c]
eligibility for clinicaltrials:NCT00087386 [clinicaltrials_resource:1dcdf36881b638564b2dbe9dd1a090ed]eligibility for clinicaltrials:NCT00368927 [clinicaltrials_resource:4b4e3edc6db2ff93cadec146a217a94e]eligibility for clinicaltrials:NCT00070525 [clinicaltrials_resource:bbc57e24ec459e18f6e64dc2c331a766]eligibility for clinicaltrials:NCT00119236 [clinicaltrials_resource:d8177edb3af609f1c135ac1b3cd473fc]eligibility for clinicaltrials:NCT00058253 [clinicaltrials_resource:efa3f75555d306a863b90f3f66cc9ff9]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
A Study to Test the Effect of Cyclosporine on the Immune System of Patients With Early HIV Disease [clinicaltrials:NCT00000880]A Study To Test An Anti-Rejection Therapy After Kidney Transplantation [clinicaltrials:NCT00000936]Drug Therapy in Lupus Nephropathy [clinicaltrials:NCT00001212]Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine [clinicaltrials:NCT00001533]clinicaltrials:NCT00001626Treatment of Dry Eye Syndrome With Cyclosporin A Eye Drops [clinicaltrials:NCT00001731]Cyclosporin Implant to Treat Uveitis [clinicaltrials:NCT00001737]Medical Treatment for Diamond Blackfan Anemia [clinicaltrials:NCT00001749]A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome [clinicaltrials:NCT00001839]The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers [clinicaltrials:NCT00001873]clinicaltrials:NCT00001964Cyclosporine A to Treat Hypertrophic Cardiomyopathy (HCM) [clinicaltrials:NCT00001965]Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation [clinicaltrials:NCT00002456]Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [clinicaltrials:NCT00002688]Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma [clinicaltrials:NCT00002759]Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant [clinicaltrials:NCT00002790]clinicaltrials:NCT00002831clinicaltrials:NCT00002832clinicaltrials:NCT00002833Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia [clinicaltrials:NCT00002961]Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation [clinicaltrials:NCT00003056]clinicaltrials:NCT00003116Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia [clinicaltrials:NCT00003145]Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma [clinicaltrials:NCT00003196]clinicaltrials:NCT00003335clinicaltrials:NCT00003553clinicaltrials:NCT00003625Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer [clinicaltrials:NCT00003920]clinicaltrials:NCT00003950Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma [clinicaltrials:NCT00003954]Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00004208]Phase II Randomized Study of Muromonab-CD3, Cyclosporine, Methylprednisolone, and Prednisone in Patients With Giant Cell Myocarditis [clinicaltrials:NCT00004482]Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer [clinicaltrials:NCT00005799]Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma [clinicaltrials:NCT00005803]Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer [clinicaltrials:NCT00005851]Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia [clinicaltrials:NCT00005935]clinicaltrials:NCT00005937Radiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First Remission [clinicaltrials:NCT00005940]Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer [clinicaltrials:NCT00005941]clinicaltrials:NCT00006184
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Cyclosporine [clinicaltrials_resource:d5ad0819e34429f7e4abc786a3f5366c]
Bio2RDF identifier
d5ad0819e34429f7e4abc786a3f5366c
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d5ad0819e34429f7e4abc786a3f5366c
identifier
clinicaltrials_resource:d5ad0819e34429f7e4abc786a3f5366c
title
Cyclosporine
@en
type
label
Cyclosporine [clinicaltrials_resource:d5ad0819e34429f7e4abc786a3f5366c]
@en